List of SBIR/STTR awards granted to HDT Bio Corp.
HDT Bio Corp.Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to HDT Bio Corp. in September, 2021 for $399,285.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43CA265564-01 | Phase I | 399,285 | September 1, 2021 | |||||||
A SBIR Phase I contract was awarded to HDT Bio Corp. in September, 2021 for $299,976.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI165100-01 | Phase I | 299,976 | September 3, 2021 | |||||||
A SBIR Phase I contract was awarded to HDT Bio Corp. in September, 2018 for $224,984.0 USD from the U.S. Department of Health & Human Services and Centers for Disease Control and Prevention. | SBIR | 1R43IP001109-01 | Phase I | 224,984 | September 30, 2018 | |||||||
A SBIR Phase I contract was awarded to HDT Bio Corp. in March, 2021 for $223,637.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI162278-01 | Phase I | 223,637 | March 16, 2021 | |||||||
A SBIR Phase I contract was awarded to HDT Bio Corp. in May, 2022 for $104,692.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI170395-01 | Phase I | 104,692 | May 10, 2022 | |||||||
A SBIR Phase I contract was awarded to HDT Bio Corp. for $299,959.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 75N93020C00028 | Phase I | 299,959 | ||||||||
A SBIR Phase I contract was awarded to HDT Bio Corp. for $221,889.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 272201800019C-0-0-0 | Phase I | 221,889 | ||||||||
A SBIR Phase I contract was awarded to HDT Bio Corp. for $599,629.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 75N93019C00037 | Phase I | 599,629 | ||||||||
A SBIR Phase I contract was awarded to HDT Bio Corp. in April, 2023 for $275,211.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI177181-01 | Phase I | 275,211 | April 14, 2023 |
